Treatment of Wastewater Containing Nonsteroidal Anti-Inflammatory Drugs Using Activated Carbon Material

被引:12
|
作者
Pirvu, Florinela [1 ,2 ]
Covaliu-Mierla, Cristina Ileana [1 ]
Paun, Iuliana [2 ]
Paraschiv, Gigel [1 ]
Iancu, Vasile [2 ]
机构
[1] Univ Politehn Bucuresti, Fac Biotech Syst Engn, Bucharest 060042, Romania
[2] Natl Res & Dev Inst Ind Ecol ECOIND, Bucharest 060652, Romania
关键词
wastewater treatment; activated carbon; anti-inflammatory drugs; ibuprofen; acetaminophen; diclofenac; ketoprofen; PHARMACEUTICALS; ACETAMINOPHEN; DEGRADATION; ENVIRONMENT;
D O I
10.3390/ma15020559
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
This study presents an adsorbent material (activated carbon) used in the treatment of wastewater with the role of removing ibuprofen, acetaminophen, diclofenac and ketoprofen pollutants. The wastewater treatment efficiencies of the activated carbon were systematically investigated using adsorption kinetics. The parameters studied were: pH (4 and 6 values of pH), initial concentration of wastewater (1, 5, and 10 mg/L), contact time (10 min), adsorbent quantity (0.1, 0.5, and 1 g), and isotherm models (Langmuir and Freundlich). The highest wastewater treatment efficiency was obtained at the 6 pH value. The determination of four anti-inflammatory drugs, frequently monitored in wastewater, was performed by a simple and fast method using the HPLC-technique-type DAD (diode array detector). The method was linear when the concentration ranged between 0.5 and 20 m/L for all compounds. The equilibrium concentration was obtained after 8 min. The octanol/water coefficient influenced the removal efficiency of the four drugs by the adsorbent material (activated carbon). The dose of activated carbon (0.1 to 1 g) significantly influenced the efficiency of wastewater treatment, which increased considerably when the dose of the adsorbent material increased. Using 1 g of the adsorbent material for the treatment of wastewater containing 1 mg/L initial concentration of pollutant compounds, the efficiencies were 98% for acetaminophen, 92% for diclofenac, 88% for ketoprofen and 96% for ibuprofen.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Sensitivity to nonsteroidal anti-inflammatory drugs
    Namazy, JA
    Simon, RA
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 89 (06) : 542 - 550
  • [22] Nonsteroidal anti-inflammatory drugs and pharyngitis
    Mazzone, Stuart B.
    Kulasekaran, Anuradha
    Shea, Tim
    Adegoke, Oluwajoba
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (12)
  • [23] NEPHROTOXICITY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    HAGLER, L
    AMERICAN FAMILY PHYSICIAN, 1984, 30 (05) : 27 - 29
  • [24] NEPHROTOXICITY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    KHOKHAR, N
    AMERICAN FAMILY PHYSICIAN, 1984, 30 (01) : 123 - 128
  • [25] The nonsteroidal anti-inflammatory drugs controversy
    Yeomans, ND
    Garas, G
    Hawkey, CJ
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2000, 29 (04) : 791 - +
  • [26] PHOTOSENSITIVITY TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
    FIGUEINEDO, A
    TEIXEIRA, E
    POIARESBAPTISTA, A
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1989, 28 (02) : 139 - 140
  • [27] Nonsteroidal Anti-inflammatory Drugs in Ophthalmology
    Kim, Stephen J.
    Flach, Allan J.
    Jampol, Lee M.
    SURVEY OF OPHTHALMOLOGY, 2010, 55 (02) : 108 - 133
  • [28] A review of nonsteroidal anti-inflammatory drugs
    Schellack, Natalie
    Schellack, Gustav
    Fourie, Johani
    SA PHARMACEUTICAL JOURNAL, 2015, 82 (03) : 8 - 18
  • [29] Topical nonsteroidal anti-inflammatory drugs
    Bhat, Chirag
    Rosenberg, Hans
    James, Daniel
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (36) : E1231 - E1231
  • [30] Novel nonsteroidal anti-inflammatory drugs
    Boutsen, Y
    Esselinckx, W
    ACTA GASTRO-ENTEROLOGICA BELGICA, 1999, 62 (04): : 421 - 424